These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 17285569)

  • 1. Enhanced inflammatory response to coronary stenting marks the development of clinically relevant restenosis.
    Caixeta AM; Brito FS; Costa MA; Serrano CV; Petriz JL; Da Luz PL
    Catheter Cardiovasc Interv; 2007 Mar; 69(4):500-7. PubMed ID: 17285569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammatory response after intervention assessed by serial C-reactive protein measurements correlates with restenosis in patients treated with coronary stenting.
    Dibra A; Mehilli J; Braun S; Hadamitzky M; Baum H; Dirschinger J; Schühlen H; Schömig A; Kastrati A
    Am Heart J; 2005 Aug; 150(2):344-50. PubMed ID: 16086941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pre-procedural plasma levels of C-reactive protein and interleukin-6 do not predict late coronary angiographic restenosis after elective stenting.
    Segev A; Kassam S; Buller CE; Lau HK; Sparkes JD; Connelly PW; Seidelin PH; Natarajan MK; Cohen EA; Strauss BH
    Eur Heart J; 2004 Jun; 25(12):1029-35. PubMed ID: 15191773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inflammatory markers, angiographic severity of coronary artery disease, and patient outcome.
    Sukhija R; Fahdi I; Garza L; Fink L; Scott M; Aude W; Pacheco R; Bursac Z; Grant A; Mehta JL
    Am J Cardiol; 2007 Apr; 99(7):879-84. PubMed ID: 17398176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preprocedural inflammatory markers do not predict restenosis after successful coronary stenting.
    Gomma AH; Hirschfield GM; Gallimore JR; Lowe GD; Pepys MB; Fox KM
    Am Heart J; 2004 Jun; 147(6):1071-7. PubMed ID: 15199358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term clinical outcome after implantation of medium Palmaz (biliary) stents in very large native coronary arteries.
    Chio FL; Liu MW; Al-Saif SM; Khan MA; Lawson D; Al-Mubarak N
    Catheter Cardiovasc Interv; 2002 May; 56(1):35-9. PubMed ID: 11979531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Percutaneous coronary intervention triggers a systemic inflammatory response in patients treated for in-stent restenosis -- comparison with stable and unstable angina.
    Kozinski M; Krzewina-Kowalska A; Kubica J; Zbikowska-Gotz M; Dymek G; Piasecki R; Sukiennik A; Grzesk G; Bogdan M; Chojnicki M; Dziedziczko A; Sypniewska G
    Inflamm Res; 2005 May; 54(5):187-93. PubMed ID: 15953990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma levels of C-reactive protein and interleukin-10 predict late coronary in-stent restenosis 6 months after elective stenting.
    Zurakowski A; Wojakowski W; Dzielski T; Milewski K; Gościńska-Bis K; Tendera M; Buszman P
    Kardiol Pol; 2009 Jun; 67(6):623-30. PubMed ID: 19618318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of changes in early inflammatory markers between sirolimus- and paclitaxel-eluting stent implantation.
    Li JJ; Yan HB; Xiang XP; Qin XW; Zhang CY
    Cardiovasc Drugs Ther; 2009 Apr; 23(2):137-43. PubMed ID: 19016317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Periprocedural soluble P- and E-selectin levels fail as predictors of clinical restenosis in patients treated with elective coronary stenting.
    Kozinski M; Kubica J; Sukiennik A; Zbikowska-Gotz M; Krzewina-Kowalska A; Radomski M; Rychter M; Bialoszynski T; Jablonski M; Demidowicz K; Grzesk G; Bogdan M; Chojnicki M; Grabczewska S; Dziedziczko A
    Int J Mol Med; 2007 Jan; 19(1):187-95. PubMed ID: 17143564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The role of cytokines in improvement of coronary restenosis risk stratification after endovascular stenting in patients with ischemic heart disease].
    Tepliakov AT; Rybal'chenko EV; Suslova TE; Mamchur SE
    Ter Arkh; 2008; 80(9):45-52. PubMed ID: 19555037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Time course of prothrombotic and proinflammatory substance release after intracoronary stent implantation.
    Wexberg P; Jordanova N; Strehblow C; Syeda B; Meyer B; Charvat S; Zorn G; Scheinig D; Wojta J; Huber K; Glogar D; Gyöngyösi M
    Thromb Haemost; 2008 Apr; 99(4):739-48. PubMed ID: 18392332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of C-reactive protein on in-stent restenosis: a meta-analysis.
    Li JJ; Ren Y; Chen KJ; Yeung AC; Xu B; Ruan XM; Yang YJ; Chen JL; Gao RL
    Tex Heart Inst J; 2010; 37(1):49-57. PubMed ID: 20200627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel predictor of restenosis and adverse cardiac events: asymmetric dimethylarginine.
    Ari H; Ari S; Erdoğan E; Tiryakioğlu O; Ustündağ Y; Huysal K; Koca V; Bozat T
    Heart Vessels; 2010 Jan; 25(1):19-26. PubMed ID: 20091394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. One month follow-up C-reactive protein may be a useful predictor of angiographic restenosis and long-term clinical outcomes after bare metal stent implantation.
    Hahn JY; Kim HS; Koo BK; Na SH; Chung JW; Youn TJ; Chung WY; Chae IH; Choi DJ; Oh BH; Lee MM; Park YB
    Int J Cardiol; 2006 May; 109(2):267-9. PubMed ID: 16644391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of carotid artery stenting on plasma interleukin-6, tumor necrosis factor-α and C-reactive protein.
    Xia ZY; Yang H; Qu HQ; Cheng WD; Wang LX
    Int Angiol; 2012 Feb; 31(1):28-32. PubMed ID: 22330622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukins and inflammatory markers in in-stent restenosis after femoral percutaneous transluminal angioplasty.
    Araújo PV; Ribeiro MS; Dalio MB; Rocha LA; Viaro F; Dellalibera Joviliano R; Piccinato CE; Évora PR; Joviliano EE
    Ann Vasc Surg; 2015; 29(4):731-7. PubMed ID: 25725274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The predictive value of inflammatory activity and markers of the adipo-insular axis on restenosis in patients with type 2 diabetes.
    Hage C; Grip L; Malmberg K; Rydén L; Wallander M; Saleh N
    Diab Vasc Dis Res; 2011 Apr; 8(2):143-9. PubMed ID: 21562066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive value of preintervention C-reactive protein on clinical outcome after directional coronary atherectomy followed by stent implantation.
    Niccoli G; Ferrante G; Mongiardo R; Perfetti M; Belloni F; Burzotta F; Porto I; Leone AM; Rebuzzi AG; Crea F
    Cardiovasc Revasc Med; 2007; 8(3):156-60. PubMed ID: 17765643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The SIRIUS-DIRECT trial: a multi-center study of direct stenting using the sirolimus-eluting stent in patients with de novo native coronary artery lesions.
    Moses JW; Weisz G; Mishkel G; Caputo R; O'shaughnessey C; Wong SC; Fischell TA; Mooney M; Williams DO; Popma JJ; Fitzgerald P; Smith S; Kuntz RE; Collins M; Cohen SA; Leon MB
    Catheter Cardiovasc Interv; 2007 Oct; 70(4):505-12. PubMed ID: 17896408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.